Levetiracetam was studied against Valproic acid and the failure to treat seizures in glioblastoma was 33% vs 50% perhaps due to its tolerability and property of enhancing p53-mediated inhibition of methylguanine-DNA methyltransferase in this patient population (64). The gene discussed is TP53; the disease is glioblastoma.